COVID news & more, 10/26/24
Wastewater levels of SARS-CoV-2 are LOW nationally. Last week's uptick in the Northeast has resolved according to CDC data. According to Sara Anne Willette’s composite wastewater data from both NWSS & WastewaterSCAN, Montana, Vermont and New Hampshire wastewater COVID levels are HIGH as of October 22, 2024. Most wastewater locations are only reporting a few times each week, so it is important to look at the date of the map in order to know if it is the most recent information. Also, there are a lot fewer sites reporting wastewater levels of virus now, which makes it more challenging to get good information. I wrote this post earlier today on “How to look up SARS-CoV-2 wastewater data in your area” which gives specific SARS-CoV-2 information about U.S. states and about other countries as well.
From: https://www.cdc.gov/nwss/rv/COVID19-nationaltrend.html
Emergency room visits for COVID in the U.S. have gone down considerably. According to JP Weiland, we are at a lull for cases, but COVID case numbers are expected to start to increase in early November. There are approximately 216,000 new COVID infections per day and 1 in every 154 Americans is currently infected. JP Weiland said that he believes that the December 2024 winter wave will be significantly lower than the recent summer wave in the West and in the South. He expects that the Northeast and the Midwest will have winter COVID waves that will be higher than their 2024 summer wave, but that their 2024-2025 winter COVID wave will have fewer cases than last year’s.
From: https://x.com/JPWeiland/status/1849946540867191171/photo/1
Variants
In the United States, the proportion of KP.3.1.1 has remained at 57% of new COVID cases for the last several weeks. Recombinant variant XEC increased from 2% to 5% to 10% to now 17% of COVID cases over the last 4 weeks. XEC is increasing in many other countries as well and is expected to become the dominant variant.
A new article from Yunlong Cao’s lab shows that these variants have special mutations, the S31del mutation of KP.3.1.1 and the T22N mutation of XEC, that allow them to add glycans to the Spike protein N-terminal domain (NTD). The additional NTD glycosylation appears to increase the ability of these variants to evade neutralizing antibodies.
Acute COVID infections, General COVID info
In a large study of 28,966 immunocompromised adults admitted to the hospital for acute COVID infection between December 2021 and February 2024, iv Remdesivir significantly decreased mortality in people not on supplemental oxygen and also in those requiring supplemental oxygen. When stratified by immunocompromising conditions, "Remdesivir was also associated with lower mortality in subgroups of patients with cancer, hematological malignancies (including leukemia, lymphoma, and multiple myeloma), and solid organ/hematopoietic stem cell transplantation."
A review of 31 studies looking at COVID transmission on airplane flights showed that there were sporadic clusters of COVID spread usually to people seated within 2 seats in any direction of the COVID infected people. Masking reduced the risk of COVID transmission.
Pregnancy
A study from Shanxi Province, China found that maternal COVID infection during early pregnancy may increase the risk of congenital heart defects in newborns. In 119 pregnant individuals infected with COVID, 10.1% of their newborns had cardiac abnormalities, compared to 4.1% in the control group. In all but one of the cases, the pregnant person was infected with COVID early, before 8 weeks of pregnancy. The study also found a significant rise overall in congenital heart disease during the pandemic, peaking at 5.5% in 2023. "The significant increase in congenital abnormalities during the COVID-19 pandemic, particularly the early gestational infections associated with specific types of cardiac abnormalities, emphasizes the need for ongoing monitoring and support for children born during the pandemic," the authors concluded.
Pediatrics
Two new studies, one from England and one from Kaiser Northern California, show that babies have a high likelihood to be hospitalized for COVID infection. The English study analyzed EHR records from 45,000 children who were admitted to the hospital for COVID infection between July 2020 and August 2023. Babies under age 1 were most likely to be admitted to the hospital for COVID and represented 43% of all pediatric hospital admissions over the three year period (July 2020 to August 2023) and 64% of pediatric COVID hospital admissions between August 2022 to 2023. For older children over age 1, the severity of hospitalizations, including critical care, decreased over time, and cases of pediatric inflammatory multisystem syndrome (PIMS-TS) dropped significantly. Infants under age 1 are the only age group where COVID hospital admissions did not decrease over time. The findings highlight that infants remain particularly vulnerable to respiratory illnesses like COVID-19 due to low immunity levels. Infants are not eligible to be vaccinated, so it is especially important to vaccinate pregnant individuals against COVID.
Photo: Freepik
Like the findings in the English study above, a new study from Kaiser Permanente Northern California (KPNC) of 1,107,799 children of whom 423 were hospitalized for COVID, found that babies under age 6 months were most likely to be hospitalized for COVID infection. Pediatric hospitalization rates were found to increase with each new SARS-CoV-2 variant. In children under 6 months of age, the incidence of hospitalization per 100,000 person-months increased from 7 during the pre-Delta period to 22.4 during the Omicron period. Black and Hispanic children, as well as kids with comorbidities, were at a higher risk of hospitalization. Teens were more likely to be admitted to ICU care. The authors conclude that "To prevent severe disease in children and adolescents, everyone eligible should be vaccinated."
Vaccines
In America, everyone over age 6 months is eligible for one dose of the 2024-2025 COVID vaccines. The CDC just updated their advice regarding certain groups. People ages 65 and older should get a second dose of vaccine approximately 6 months after their first. Moderately to severely immunocompromised people of any age can now get two or more doses of the updated COVID vaccine per year under shared clinical decision making with their clinician. “The recommendation acknowledges the increased risk of severe disease from COVID-19 in older adults and those who are immunocompromised, along with the currently available data on vaccine effectiveness and year-round circulation of COVID-19.”
Novavax
The FDA has put the clinical trials of Novavax’s combined COVID-Influenza and its stand alone Influenza vaccine on hold after a trial participant reported nerve damage after receiving the combined vaccine.
Vaccines and Mucosal Immunity
The entry point of the SARS-CoV-2 virus is often through the nasal mucosa. This week, there were two new articles in Science magazine about mucosal immunity in the nose after COVID vaccination. The first article by Lasrado et al. showed that the XBB.1.5 mRNA intramuscular vaccine from last winter substantially increased neutralizing antibodies in the blood, but did not increase mucosal IgA antibody levels in the nose.
The second study showed that intramuscular mRNA COVID vaccines can increase mucosal immunity against SARS-CoV-2, but not in the expected way. Usually, IgA antibodies are made in nasal mucosal tissues, but in this case, antibodies found in the mucosa were actually IgG that migrated from the bloodstream into the nose. Other studies have shown that giving a nasal spray booster vaccine after mRNA intramuscular vaccination causes an increase of IgA antibodies against SARS-CoV-2 in the nasal mucosa which can help to block infection.
Vaccine expert Dr. Vipin Vashishtha tweeted, “These differing results by two studies may be due to the number of SARS-CoV-2 vaccinations or exposures, time since last exposure, and experimental approaches, but this pair of papers underscores the need to better understand the mucosal immune response in humans.”
Long COVID
To figure out the pathophysiology of SARS-CoV-2 spread in the body, and to understand possible viral persistence in post-acute COVID, scientists from France used a radiolabeled antibody to SARS-CoV-2 which they used to follow viral spread over time using Immuno PET scans in monkeys. Three months after SARS-CoV-2 infection, the researchers also found persistent SARS-CoV-2 antigens in the lungs and brain of the non-human primates on repeat PET scan. Histopathology confirmed these findings.
This reminds me of a recent study from UCSF in humans that used a T cell radioactive tracer on Immuno PET scan showing that SARS-CoV-2 can persist chronically in the gastrointestinal system and in other organs of people with Long COVID for over 2 years. In people with brain fog and fatigue, the gut and the spinal cord lit up on Immuno PET scan. Those with lingering pulmonary symptoms had immune activation in their lungs. Long COVID patient Ezra shared his Immuno PET scan from the study and explained the findings in this fascinating video clip.
Long COVID Advocacy
Two patient-researchers with Long COVID, Julia Moore Vogel and Charlie McCone, wrote a piece in STAT news about the difficulties living with Long COVID, especially since there are no FDA approved treatments and since research is moving very slowly. 400 million people worldwide are suffering immensely from the disease. They recommend that until there are FDA approved treatments, health care providers should allow patients to try off-label drugs that have helped other people with Long COVID. They recommend guidelines and education about Long COVID for doctors regarding which off label treatments are most helpful for Long COVID symptoms.
A study of young US Marines with mild COVID infections showed that 24.7% had post-acute sequelae of COVID (PASC) with symptoms like loss of taste or smell, shortness of breath, and cough. One year after mild or asymptomatic COVID infection, the young recruits had higher levels of depression and anxiety, and did worse on physical fitness tests due to slower run times. The findings show that even mild or asymptomatic COVID-19 can lead to significant long-term health effects in healthy young adults.
A group from Sweden looked at the endothelial cells that line small blood vessels in people with post-acute COVID-19 syndrome (PACS or Long COVID). They found that 2 years after mild COVID infection, 41% of patients with PACS had microvascular endothelial dysfunction. N-terminal pro-B type natriuretic peptide (NT-proBNP) is a biomarker that increases with heart failure and cardiovascular stress. Long COVID patients with microvascular dysfunction were also found to have increasing levels of NT-proBNP over time, suggesting a link between endothelial dysfunction and potential heart-related complications in people with Long COVID.
For healthcare providers, Stanford’s Long COVID clinical seminar “Unraveling Long COVID: Advances in Clinical Practice” is now available online.
H5N1
According to the Seattle Times, 8 people who worked at a commercial egg farm in Washington State have tested positive for H5N1 bird flu on preliminary tests. Two of the 8 preliminary positive cases have been confirmed by the CDC and the other 6 cases are pending. The egg farm has been closed.
Good news: CDC testing shows that there was no transmission of H5N1 bird flu between the Missouri H5N1 patient and 5 healthcare workers. There was no cluster. Genetic testing of the virus shows that the person was infected with the same H5N1 variant as found in cattle.
The CDC summarizes human H5N1 Bird Flu cases in a table that is updated Monday evenings at 5pm ET at https://www.cdc.gov/bird-flu/situation-summary/index.html
Other news
Two groups from the University of California have developed a way to repair genetic mutations before birth to potentially stop neurodevelopmental genetic conditions like Angelman and Rett syndromes. Using lipid nanoparticles (LNPs), the researchers were able to deliver Cas9 mRNA to 30% of fetal brain cells in mice which allowed the disease mutations to be repaired. This innovative treatment may some day help treat genetic disorders in-utero, preventing severe disease from developing after birth. “The implications of this tool for treating neurodevelopmental conditions are profound. We can potentially correct genetic anomalies at a foundational level during critical periods of brain development,” said the study’s senior author Aijun Wang, a UC Davis professor of surgery and biomedical engineering.
From: https://pubs.acs.org/doi/10.1021/acsnano.4c05169
The CDC reported an E. Coli outbreak that is linked to McDonald’s Quarter Pounder hamburgers. As of 10/25/24, Taylor Farms initiated a voluntary recall of their onions that may have been used on the Quarter Pounder burgers.
The FDA recalled 7,107 bottles of Cymbalta (Duloxetine) made by Towa Pharmaceutical Europe this week as the medication could cause "temporary or medically reversible adverse health consequences." Cymbalta (Duloxetine) treats depression, anxiety and chronic nerve pain. It is important NOT to stop Cymbalta without tapering off of it as that could cause withdrawal symptoms including severe vomiting.
Walking pneumonia is a bacterial respiratory infection caused by Mycoplasma pneumoniae. Cases have been increasing since last spring and remain high, especially for young children ages 2-4 years which is unusual.
“For his impact as an actor, a literacy advocate, and a storyteller” – LeVar Burton was awarded the 2023 National Humanities Medal from the White House.
From: https://x.com/levarburton/status/1849075947158290727
Orthodox monks in upstate New York breed German Shepherd puppies and train other dogs for financial and spiritual support.
Photo: https://newskete.org/our-life-with-dogs
Have a good rest of your weekend,
Ruth Ann Crystal MD
________________________________________________________________
COVID news notes:
US Variant tracker: https://covid.cdc.gov/covid-data-tracker/#variant-proportions
KP.3.1.1 stable at 57%
XEC went from 2% to 5% to 10% to now 17% over the last 4 weeks.
CDC COVID data tracker: https://covid.cdc.gov/covid-data-tracker/index.html#datatracker-home
COVID Emergency Dept visits: https://covid.cdc.gov/covid-data-tracker/#ed-visits_all_ages_combined
CDC Respiratory viruses (COVID, Flu, RSV) Hospitalizations (for those states reporting): https://www.cdc.gov/resp-net/dashboard/index.html
This may look a lot different after November 1st when all states will start reporting.
Walgreens positivity rate: https://www.walgreens.com/businesssolutions/covid-19-index.jsp
US Wastewater Monitoring:
CDC wastewater reporting: https://www.cdc.gov/nwss/rv/COVID19-nationaltrend.html
CDC wastewater map: https://www.cdc.gov/nwss/rv/COVID19-currentlevels.html
Wyoming and New Mexico are HIGH this week. (Well, through 10/19/24)
National SARS-CoV-2 data from Sara Anne Willette: https://iowacovid19tracker.org/
Map date October 22, 2024
US Composite Wastewater Data: from both NWSS & WastewaterSCAN
Most places only report a few times per week, so it is important to look at the map date to see if this is the latest information.
Montana, Vermont and New Hampshire are HIGH (Pink)
Wastewater SCAN: https://data.wastewaterscan.org/
There are a lot fewer sites reporting wastewater SARS-CoV-2 levels in most states now. For instance, there are only 2 sites reporting now for Massachusetts.
California statewide view https://buff.ly/3YObiul
Napa, SF Oceanside, Santa Cruz are all medium now.
Sewer Coronavirus Alert Network (SCAN) project by Stanford University:
As of 10/22/24
Santa Clara County wastewater: https://publichealth.santaclaracounty.gov/health-information/health-data/disease-data/covid-19/covid-19-wastewater
Marin county: https://coronavirus.marinhhs.org/surveillance
Los Angeles County:
Ohio
Las Vegas
What happened in Las Vegas since yesterday?
___________________________________________________________________________
To look up wastewater information specific to your location, please see my new post here: https://drruth.substack.com/p/how-to-look-up-sars-cov-2-wastewater
JP Weiland: https://twitter.com/JPWeiland
https://x.com/JPWeiland/status/1849946540867191171
Oct 25th update:
Currently at low levels, though expect the numbers to start trending up in early November after the lull.
Estimates:
216,000 new infections/day
1 in every 154 people currently infected
Numbers are 63% below 12-month average
From: https://x.com/JPWeiland/status/1849946540867191171/photo/1
Michael Hoerger modeling: http://pmc19.com/data/, https://twitter.com/michael_hoerger
UK:
UKHSA Dashboard: https://ukhsa-dashboard.data.gov.uk/
UK COVID PCR Test Positivity Map: https://jamestindall.info/skeuomorphology/ladb_covid/index.html
UK
10/22/24 https://x.com/_CatintheHat/status/1848767458481737969
PCR positivity slightly HIGHER than last Winter’s peak…
Hospitalisations slightly LOWER…
True trend somewhere in the middle…
To summarise: Comparing current trends in Covid positivity rate & hospitalisations against the Covid prevalence last Winter, my best guess is that the current prevalence [of COVID] lies somewhere between: 3% (equivalent to 1 in 33 people) AND 5% (equivalent to 1 in 20 people).
From: https://x.com/_CatintheHat/status/1848767478190538790/photo/1
Variants
10/23/24 BioRxiV (Yunlong Cao's lab): Enhanced immune evasion of SARS-CoV-2 KP.3.1.1 and XEC through NTD glycosylation https://buff.ly/3YmZoYl
Acute COVID infections, General COVID info
10/15/24 Clinical Infectious Diseases: Remdesivir-associated survival outcomes among immunocompromised patients hospitalized for COVID-19: real-world evidence from the Omicron dominant era https://buff.ly/48pRJNB
10/22/24 MedRxiV: Transmission of SARS-CoV-2 on aircraft: A scoping review https://buff.ly/4f7YvtO
Pregnancy
10/23/24 CIDRAP: Maternal COVID infections may affect newborn heart development https://buff.ly/3C9Yffh
"The significant increase in congenital abnormalities during the COVID-19 pandemic, particularly the early gestational infections associated with specific types of cardiac abnormalities, emphasizes the need for ongoing monitoring and support for children born during the pandemic," the authors concluded.
Original article:
10/22/24 Nature Scientific Reports: The association of increased incidence of congenital heart disease in newborns with maternal COVID-19 infection during pregnancy https://buff.ly/3BUrL8K
Pediatrics
Photo: Freepik
10/17/24 Journal of Pediatrics: Trends in Pediatric Hospital Admissions Caused or Contributed by SARS-CoV-2 Infection in England https://buff.ly/3YB1xBm
Christina Pagel’s tweet thread: https://x.com/chrischirp/status/1847649507321786645
The pandemic is as bad as it ever was for babies - in year to Aug 2023, 6,300 babies under 1 were admitted to hospital wholly or partly BECAUSE of Covid.
They are ONLY age group where admissions have NOT gone down over time
Babies are not vaccinated
Over the whole period, Covid admissions in infants accounted for 43% of ALL admissions in children under 18 (19.7K/45.9K).
In the 12 months Aug 2022-23, infants were *64% of all covid child admissions*
In summary, our new paper shows clearly that for babies, the pandemic is as bad as it ever was.
There are things we can do to protect them, and we should.
Babies under 6 months cannot be vaccinated.
In the UK children under age 5 are not vaccinated for COVID either.
It is important to offer COVID vaccination to pregnant individuals to protect their babies.
10/21/24 Influenza and Other Respiratory Viruses Journal (Kaiser): Incidence and Risk of Coronavirus Disease 2019 Hospitalization Among Unvaccinated Children https://buff.ly/48kNWRD
Vaccines
10/23/24 CDC Press Release: The CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised https://buff.ly/3C9ojHp
From: https://www.cdc.gov/media/releases/2024/s1023-covid-19-vaccine.html
10/23/24 Healio: ACIP recommends 2nd COVID shot for some, lowering age for pneumococcal vaccination https://buff.ly/4e4QCEi
The ACIP recommended second doses for people aged 65 years or older and for moderately or severely immunocompromised people.
The committee also recommended lowering the range of pneumococcal vaccination to 50 years.
Vaccines and Mucosal Immunity
10/23/24 Science: SARS-CoV-2 XBB.1.5 mRNA booster vaccination elicits limited mucosal immunity https://buff.ly/3A7aIjr
https://www.science.org/doi/10.1126/scitranslmed.adp8920
However, another new study by Lasrado et al. observed no obvious increase in neutralizing antibody titers after XBB.1.5 mRNA booster vaccination.
They found that XBB.1.5 mRNA booster did not augment mucosal NAbs or mucosal IgA responses, although acute SARS-CoV-2 XBB infection substantially increased mucosal antibody responses.
The Lasrado et al. study shows that current XBB.1.5 mRNA boosters substantially enhance peripheral antibody responses but do not robustly increase mucosal antibody responses.
These differing results by two studies may be due to the number of SARS-CoV-2 vaccinations or exposures, time since last exposure, and experimental approaches, but this pair of papers underscores the need to better understand the mucosal immune response in humans.
10/23/24 Science: Repeated COVID-19 mRNA-based vaccination contributes to SARS-CoV-2 neutralizing antibody responses in the mucosa https://buff.ly/3NAKoRZ
https://www.science.org/doi/10.1126/scitranslmed.adn2364
Repeated COVID vaccinations enhance mucosal immunity against the virus! A NEW study finds that individuals who received multiple doses of mRNA vaccines exhibited a marked increase in neutralizing antibodies in nasal secretions, which are essential for blocking viral entry.
They found that most mucosal neutralizing antibodies were of systemic origin, w/ antibodies circulating in blood migrating to respiratory mucosa in the nose, suggesting that repeated vaccination stimulates systemic antibody production that can reach mucosal membranes.
This study provides compelling evidence that repeated mRNA vaccinations can improve mucosal antibody responses, or stimulate pre-existing infection induced mucosal responses, which are vital for preventing infection at the entry points of the virus.
10/23/24 @vipintukur https://x.com/vipintukur/status/1849303047593140249
10/16/24 Reuters: US FDA pauses Novavax's trial of combo COVID-flu shot on safety concerns https://buff.ly/40rnLqP
"The U.S. Food and Drug Administration has put on hold a trial of Novavax's (NVAX.O), COVID-influenza and its standalone flu vaccines after a participant who took the combination shot reported nerve damage."
Long COVID
To better understand the pathophysiology of SARS-CoV-2 spread in the body, and to understand possible viral persistence in post-acute COVID, scientists from France used a radiolabeled antibody to SARS-CoV-2 and were able to follow viral spread over time using Immuno PET scans in monkeys. Three months after SARS-CoV-2 infection, the researchers also found persistent SARS-CoV-2 antigens in the lung and brain of the non-human primates.
This reminds me of the UCSF study looking at T cell activation on Immune PET/CT scans of people with Long COVID.
7/3/24 Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection https://www.science.org/doi/10.1126/scitranslmed.adk3295
Long COVID patient Ezra shows his Immuno PET scan from the study and explains the findings in a fascinating video here.
Long Covid patients deserve to try off-label drugs | STAT https://buff.ly/3C0hY11
10/24/24 STAT News: ‘Do no harm’ is hurting 400 million long Covid patients worldwide
"We call upon the Department of Health and Human Services to find ways to approve, pay for, and collect and disseminate information about treatment options for long Covid and other infection-associated chronic conditions."
“Do no harm” means providing access to treatments — not withholding them.
By Julia Moore Vogel and Charlie McCone
Moore Vogel is a long Covid patient-researcher at Scripps Research and the Patient Led Research Collaborative (PLRC). Charlie McCone is a long Covid patient advocate, is a member of the PLRC, and has served as a patient representative on the NIH RECOVER clinical trials arm.
11/2024 Lancet Americas: Clinical and functional assessment of SARS-CoV-2 sequelae among young marines – a panel study https://buff.ly/4e1nJsA
https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(24)00236-9/fulltext
10/16/24 American Journal of Medicine: Post-acute COVID-19 syndrome: prevalence of peripheral microvascular endothelial dysfunction and associations with NT-proBNP dynamics https://buff.ly/3NzqWVt
https://www.amjmed.com/article/S0002-9343%2824%2900642-9/fulltext
In people with #LongCOVID 2 years after a mild COVID infection, 41% had endothelial dysfunction of small blood vessels that was associated with increasing levels of NT-proBNP over time.
For healthcare providers, Stanford’s Long COVID clinical seminar is now available online.
Unraveling Long COVID: Advances in Clinical Practice
https://stanford.cloud-cme.com/course/courseoverview?P=5&EID=52228
10/23/24 L Ward https://x.com/Lwardo4/status/1849124459854340182
Tweet about people working at the RECOVER trial from the NIH refuse to mask around people with Long COVID who are a part of the study.
H5N1
10/25/24 CDC sends help as more WA egg farm workers test positive for bird flu https://buff.ly/4eX4txD
According to the Seattle Times, 8 people who worked at a commercial egg farm have tested positive for H5N1 bird flu on preliminary tests. Two of the 8 preliminary positive cases have been confirmed by the CDC and the other 6 cases are pending.
CDC H5 Bird Flu page: https://www.cdc.gov/bird-flu/situation-summary/index.html
The table of human H5N1 Bird Flu cases is updated Monday evenings.
10/24/24 STAT News: CDC testing suggests Missouri did not see a cluster of bird flu cases https://buff.ly/3C753KB
https://statnews.com/2024/10/24/missouri-h5n1-bird-flu-cases-cdc-human-transmission-unlikely/
Good news: CDC testing shows that there was no transmission of H5N1 bird flu between the Missouri patient and the 5 healthcare workers. There was no cluster.
Genetic testing of the virus shows that the person was infected with the same H5N1 variant as found in cattle.
Other news:
10/24/24 ACS Nano (UC Davis and UC Berkeley): Widespread Gene Editing in the Brain via In Utero Delivery of mRNA Using Acid-Degradable Lipid Nanoparticles https://buff.ly/48paSPQ
https://pubs.acs.org/doi/10.1021/acsnano.4c05169
https://pubs.acs.org/cms/10.1021/acsnano.4c05169/asset/images/large/nn4c05169_0007.jpeg
From: https://pubs.acs.org/doi/10.1021/acsnano.4c05169
10/24/24 Neuroscience News: In-Utero Gene Editing Could Halt Neurodevelopmental Disorders https://buff.ly/4e8xKEq
“The implications of this tool for treating neurodevelopmental conditions are profound. We can potentially correct genetic anomalies at a foundational level during critical periods of brain development,” said the study’s senior author Aijun Wang, a UC Davis professor of surgery and biomedical engineering.
10/22/24 CDC: E. coli Outbreak Linked to McDonald’s Quarter Pounders https://buff.ly/4hj9pyK
“New as of 10/25: More illnesses have been reported and everyone interviewed continues to report eating at McDonald’s before their illness started. The most recent illness started on October 10. Taylor Farms has initiated a voluntary recall of some onions sent to food service operators. Due to the product actions taken by both companies, CDC believes the risk to the public is very low.”
Photo: Evan Amos
10/22/24 CBS news: Thousands of duloxetine bottles, an antidepressant sold as Cymbalta, recalled over toxic chemical https://buff.ly/3Ugklmv
10/22/24 American Academy of Pediatrics: Mycoplasma pneumoniae infections increasing among children, CDC data reveal https://buff.ly/40gIa1E
10/16/24 KFF Health News: More Mobile Clinics Are Bringing Long-Acting Birth Control to Rural Areas https://buff.ly/3NBlaTp
UniMóvil, is part of the Healthy Mujeres program at the University of Texas Rio Grande Valley School of Medicine.
Write your name in LANDSAT from NASA: https://landsat.gsfc.nasa.gov/apps/YourNameInLandsat-main/index.html
10/23/24 LeVar Burton https://x.com/levarburton/status/1849075947158290727
10/20/24 AP: Learning about God from dogs, Orthodox monks breed and train canines in upstate New York monastery https://buff.ly/3Yv4vab
Thank you so very much.